Daniel Napierkowski, MD

Daniel Napierkowski, MD
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Department Regional Hospital Administration
Primary Location Marymount Hospital
Type of Doctor Adults Only
Languages English
Surgeon No
Locations
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About Daniel Napierkowski, MD

Daniel Napierkowski, MD, is the President at Euclid Hospital.  He has served as Chairman of Regional Practice Anesthesiology since 2010.  While serving as president, he continues a clinical practice at Euclid 1-2 days a week.
Education & Professional Highlights

Education & Professional Highlights

Appointed
1997

Education & Fellowships

Residency - UPMC Mercy Hospital of Pittsburgh
Anesthesiology
Pittsburgh, PA USA
1990

Internship - Western Pennsylvania Hospital
Medicine
Pittsburgh, PA USA
1987

Medical School - University of Pittsburgh School of Medicine
MD
Pittsburgh, PA USA
1986

Undergraduate - Duquesne University School of Nursing
Pharmacy
Pittsburgh, PA USA
1979

Certifications

  • Anesthesiology

Specialty Interests

acute postoperative pain management, ambulatory, ambulatory anesthesia, anesthesia for orthopaedic surgery, anesthesiology, anesthesiology and pain, anesthesiology practice, difficult airway management, neuroanesthesia, outpatient anesthesia, regional anesthesia

Research & Publications

Research & Publications

See publications for Daniel Napierkowski, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/4/2016, Dr. Napierkowski has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Related Videos Featuring Daniel Napierkowski, MD